Difference between revisions of "Hagerstrand D, et al. Neuro-Oncology (2011) cited as Ref 82 in DOI: 10.1038/s41392-020-0110-5 (Q9345)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Hagerstrand D, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 1178-1191, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1093/neuonc/nor113 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 21940738 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2011
| ||||||||||||||
| Property / Publication Date: 2011 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Neuro-Oncology | ||||||||||||||
| Property / Published In Name String: Neuro-Oncology / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 13 | ||||||||||||||
| Property / Volume: 13 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile (English) | ||||||||||||||
| Property / title: Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 1178-1191 | ||||||||||||||
| Property / Page(s): 1178-1191 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:29, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hagerstrand D, et al. Neuro-Oncology (2011) cited as Ref 82 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hagerstrand D
0 references
2011
0 references
Neuro-Oncology
0 references
13
0 references
Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile (English)
0 references
1178-1191
0 references
